If we had a pancoronavirus vaccine, revising existing Covid-19 vaccines year in and year out wouldn’t be necessary. According to two new studies, nanoparticle immunization technology might be the key.
If we had a pancoronavirus vaccine, revising existing Covid-19 vaccines year in and year out wouldn’t be necessary. According to two new studies, nanoparticle immunization technology might be the key.